Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 55
Filtrar
1.
J Virol ; 98(1): e0165423, 2024 Jan 23.
Artículo en Inglés | MEDLINE | ID: mdl-38169290

RESUMEN

Jeilongviruses are emerging single-stranded negative-sense RNA viruses in the Paramyxoviridae family. Tailam paramyxovirus (TlmPV) is a Jeilongvirus that was identified in 2011. Very little is known about the mechanisms that regulate viral replication in these newly emerging viruses. Among the non-structural viral proteins of TlmPV, the C protein is predicted to be translated from an open reading frame within the phosphoprotein gene through alternative translation initiation. Though the regulatory roles of C proteins in virus replication of other paramyxoviruses have been reported before, the function of the TlmPV C protein and the relevant molecular mechanisms have not been reported. Here, we show that the C protein is expressed in TlmPV-infected cells and negatively modulates viral RNA replication. The TlmPV C protein interacts with the P protein, negatively impacting the interaction between N and P, resulting in inhibition of viral RNA replication. Deletion mutagenesis studies indicate that the 50 amino-terminal amino acid residues of the C protein are dispensable for its inhibition of virus RNA replication and interaction with the P protein.IMPORTANCETailam paramyxovirus (TlmPV) is a newly identified paramyxovirus belonging to the Jeilongvirus genus, of which little is known. In this work, we confirmed the expression of the C protein in TlmPV-infected cells, assessed its function, and defined a potential mechanism of action. This is the first time that the existence of a Jeilongvirus C protein has been confirmed and its role in viral replication has been reported.


Asunto(s)
Paramyxovirinae , Proteínas Virales , Replicación Viral , Paramyxovirinae/genética , Paramyxovirinae/fisiología , ARN Viral/genética , Proteínas Virales/genética , Animales , Cricetinae , Línea Celular
2.
J Virol ; 97(1): e0180222, 2023 01 31.
Artículo en Inglés | MEDLINE | ID: mdl-36521070

RESUMEN

Tailam paramyxovirus (TlmPV) was identified in Sikkim Rats in Hong Kong, China in 2011. Its negative sense RNA genome is similar to J paramyxovirus (JPV) and Beilong paramyxovirus (BeiPV), the prototypes of the recently established genus Jeilongvirus. TlmPV genome is predicted to have eight genes in the order 3'-N-P/V/C-M-F-SH-TM-G/X-L-5'. The predicted size of the TlmPV G protein is 1,052 amino acid (aa) residues and much larger than G proteins of typical paramyxoviruses, which are often less than 800 aa. In addition to G open reading frame (ORF) in the G gene, another ORF, termed ORF-X exists in the G gene transcript. Similar ORF-X exists in JPV and BeiPV G gene, but their expression in virus-infected cells has not been confirmed. In this study, we generated infectious TlmPV using a newly developed reverse genetics system. We have found that the G protein of TlmPV is truncated in cultured cells: stop codons emerged in the G open reading frame, resulting in deletions of amino acid residues beyond residue 732. We have obtained infectious TlmPV lacking the C-terminal 307 aa (rTlmPV-G745) and TlmPV lacking the C-terminal 306 aa and the ORF-X (rTlmPV-GΔ746-X). The recombinant TlmPVs lacking the C-terminal 300 aa reach a higher peak viral titer and have improved genome stability in tissue cultured cells. The work indicates that the C-terminal of the G protein of TlmPV and ORF-X are not required for replication in tissue culture cells, and the deletion of the C-terminal confers a growth advantage in tissue culture cells. IMPORTANCE TlmPV is a member of the recently established genus Jeilongvirus. TlmPV encodes a large G protein and its G gene contains ORF-X. In this work, infectious TlmPV was recovered using reverse genetics. Using this system, we have demonstrated that 300 aa of C-terminal of G and the ORF-X are not required for viral replication in tissue culture cells.


Asunto(s)
Proteínas de Unión al GTP , Sistemas de Lectura Abierta , Paramyxovirinae , Replicación Viral , Animales , Ratas , Células Cultivadas , Proteínas de Unión al GTP/genética , Paramyxovirinae/genética , Paramyxovirinae/fisiología
3.
Viruses ; 14(1)2022 01 12.
Artículo en Inglés | MEDLINE | ID: mdl-35062341

RESUMEN

Particles of many paramyxoviruses include small amounts of proteins with a molecular weight of about 20 kDa. These proteins, termed "C", are basic, have low amino acid homology and some secondary structure conservation. C proteins are encoded in alternative reading frames of the phosphoprotein gene. Some viruses express nested sets of C proteins that exert their functions in different locations: In the nucleus, they interfere with cellular transcription factors that elicit innate immune responses; in the cytoplasm, they associate with viral ribonucleocapsids and control polymerase processivity and orderly replication, thereby minimizing the activation of innate immunity. In addition, certain C proteins can directly bind to, and interfere with the function of, several cytoplasmic proteins required for interferon induction, interferon signaling and inflammation. Some C proteins are also required for efficient virus particle assembly and budding. C-deficient viruses can be grown in certain transformed cell lines but are not pathogenic in natural hosts. C proteins affect the same host functions as other phosphoprotein gene-encoded proteins named V but use different strategies for this purpose. Multiple independent systems to counteract host defenses may ensure efficient immune evasion and facilitate virus adaptation to new hosts and tissue environments.


Asunto(s)
Inmunidad Innata/inmunología , Infecciones por Paramyxoviridae/inmunología , Paramyxovirinae/fisiología , Fosfoproteínas/inmunología , Proteínas Virales/inmunología , Replicación Viral/fisiología , Animales , Virus Interferentes Defectuosos , Genoma Viral , Humanos , Evasión Inmune , Inflamasomas , Sistemas de Lectura Abierta , Paramyxovirinae/genética , Fosfoproteínas/química , Fosfoproteínas/genética , Fosfoproteínas/metabolismo , Filogenia , Proteínas Virales/química , Proteínas Virales/genética , Proteínas Virales/metabolismo , Ensamble de Virus
4.
Viruses ; 13(8)2021 08 20.
Artículo en Inglés | MEDLINE | ID: mdl-34452523

RESUMEN

Bats have been identified as the natural hosts of several emerging zoonotic viruses, including paramyxoviruses, such as Hendra and Nipah viruses, that can cause fatal disease in humans. Recently, African fruit bats with populations that roost in or near urban areas have been shown to harbour a great diversity of paramyxoviruses, posing potential spillover risks to public health. Understanding the circulation of these viruses in their reservoir populations is essential to predict and prevent future emerging diseases. Here, we identify a high incidence of multiple paramyxoviruses in urine samples collected from a closed captive colony of circa 115 straw-coloured fruit bats (Eidolon helvum). The sequences detected have high nucleotide identities with those derived from free ranging African fruit bats and form phylogenetic clusters with the Henipavirus genus, Pararubulavirus genus and other unclassified paramyxoviruses. As this colony had been closed for 5 years prior to this study, these results indicate that within-host paramyxoviral persistence underlies the role of bats as reservoirs of these viruses.


Asunto(s)
Quirópteros/virología , Reservorios de Enfermedades/virología , Paramyxovirinae/fisiología , Animales , Quirópteros/crecimiento & desarrollo , Quirópteros/orina , Femenino , Masculino , Paramyxovirinae/clasificación , Paramyxovirinae/genética , Paramyxovirinae/aislamiento & purificación , Filogenia , Orina/virología
5.
Viruses ; 12(12)2020 12 02.
Artículo en Inglés | MEDLINE | ID: mdl-33276587

RESUMEN

The paramyxo- and pneumovirus family includes a wide range of viruses that can cause respiratory and/or systemic infections in humans and animals. The significant disease burden of these viruses is further exacerbated by the limited therapeutics that are currently available. Host cellular proteins that can antagonize or limit virus replication are therefore a promising area of research to identify candidate molecules with the potential for host-targeted therapies. Host proteins known as host cell restriction factors are constitutively expressed and/or induced in response to virus infection and include proteins from interferon-stimulated genes (ISGs). Many ISG proteins have been identified but relatively few have been characterized in detail and most studies have focused on studying their antiviral activities against particular viruses, such as influenza A viruses and human immunodeficiency virus (HIV)-1. This review summarizes current literature regarding host cell restriction factors against paramyxo- and pneumoviruses, on which there is more limited data. Alongside discussion of known restriction factors, this review also considers viral countermeasures in overcoming host restriction, the strengths and limitations in different experimental approaches in studies reported to date, and the challenges in reconciling differences between in vitro and in vivo data. Furthermore, this review provides an outlook regarding the landscape of emerging technologies and tools available to study host cell restriction factors, as well as the suitability of these proteins as targets for broad-spectrum antiviral therapeutics.


Asunto(s)
Interacciones Huésped-Patógeno , Infecciones por Paramyxoviridae/virología , Paramyxovirinae/fisiología , Infecciones por Pneumovirus/virología , Pneumovirus/fisiología , Animales , Biomarcadores , Regulación Viral de la Expresión Génica , Especificidad del Huésped , Interacciones Huésped-Patógeno/genética , Interacciones Huésped-Patógeno/inmunología , Humanos , Inmunidad Innata , Infecciones por Paramyxoviridae/genética , Infecciones por Paramyxoviridae/metabolismo , Infecciones por Pneumovirus/genética , Infecciones por Pneumovirus/metabolismo , Tropismo Viral , Replicación Viral
6.
Viruses ; 12(3)2020 03 20.
Artículo en Inglés | MEDLINE | ID: mdl-32245118

RESUMEN

Paramyxoviruses and pneumoviruses infect cells through fusion (F) protein-mediated merger of the viral envelope with target membranes. Members of these families include a range of major human and animal pathogens, such as respiratory syncytial virus (RSV), measles virus (MeV), human parainfluenza viruses (HPIVs), and highly pathogenic Nipah virus (NiV). High-resolution F protein structures in both the metastable pre- and the postfusion conformation have been solved for several members of the families and a number of F-targeting entry inhibitors have progressed to advanced development or clinical testing. However, small-molecule RSV entry inhibitors have overall disappointed in clinical trials and viral resistance developed rapidly in experimental settings and patients, raising the question of whether the available structural information may provide a path to counteract viral escape through proactive inhibitor engineering. This article will summarize current mechanistic insight into F-mediated membrane fusion and examine the contribution of structural information to the development of small-molecule F inhibitors. Implications are outlined for future drug target selection and rational drug engineering strategies.


Asunto(s)
Antivirales/química , Antivirales/farmacología , Descubrimiento de Drogas , Paramyxovirinae/fisiología , Pneumovirus/fisiología , Internalización del Virus/efectos de los fármacos , Animales , Sitios de Unión , Descubrimiento de Drogas/métodos , Humanos , Modelos Moleculares , Infecciones por Paramyxoviridae/tratamiento farmacológico , Infecciones por Paramyxoviridae/virología , Paramyxovirinae/efectos de los fármacos , Pneumovirus/efectos de los fármacos , Infecciones por Pneumovirus/tratamiento farmacológico , Infecciones por Pneumovirus/virología , Unión Proteica , Relación Estructura-Actividad
7.
J Virol ; 93(17)2019 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-31189700

RESUMEN

We have developed a high-throughput sequencing (HTS) workflow for investigating paramyxovirus transcription and replication. We show that sequencing of oligo(dT)-selected polyadenylated mRNAs, without considering the orientation of the RNAs from which they had been generated, cannot accurately be used to analyze the abundance of viral mRNAs because genomic RNA copurifies with the viral mRNAs. The best method is directional sequencing of infected cell RNA that has physically been depleted of ribosomal and mitochondrial RNA followed by bioinformatic steps to differentiate data originating from genomes from viral mRNAs and antigenomes. This approach has the advantage that the abundance of viral mRNA (and antigenomes) and genomes can be analyzed and quantified from the same data. We investigated the kinetics of viral transcription and replication during infection of A549 cells with parainfluenza virus type 2 (PIV2), PIV3, PIV5, or mumps virus and determined the abundances of individual viral mRNAs and readthrough mRNAs. We found that the mRNA abundance gradients differed significantly between all four viruses but that for each virus the pattern remained relatively stable throughout infection. We suggest that rapid degradation of non-poly(A) mRNAs may be primarily responsible for the shape of the mRNA abundance gradient in parainfluenza virus 3, whereas a combination of this factor and disengagement of RNA polymerase at intergenic sequences, particularly those at the NP:P and P:M gene boundaries, may be responsible in the other viruses.IMPORTANCE High-throughput sequencing (HTS) of virus-infected cells can be used to study in great detail the patterns of virus transcription and replication. For paramyxoviruses, and by analogy for all other negative-strand RNA viruses, we show that directional sequencing must be used to distinguish between genomic RNA and mRNA/antigenomic RNA because significant amounts of genomic RNA copurify with poly(A)-selected mRNA. We found that the best method is directional sequencing of total cell RNA, after the physical removal of rRNA (and mitochondrial RNA), because quantitative information on the abundance of both genomic RNA and mRNA/antigenomes can be simultaneously derived. Using this approach, we revealed new details of the kinetics of virus transcription and replication for parainfluenza virus (PIV) type 2, PIV3, PIV5, and mumps virus, as well as on the relative abundance of the individual viral mRNAs.


Asunto(s)
Perfilación de la Expresión Génica/métodos , Infecciones por Paramyxoviridae/virología , Paramyxovirinae/fisiología , ARN Mensajero/genética , Secuenciación Completa del Genoma/métodos , Células A549 , Regulación Viral de la Expresión Génica , Tamaño del Genoma , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Paramyxovirinae/clasificación , Paramyxovirinae/patogenicidad , ARN Viral/genética , Especificidad de la Especie , Replicación Viral
8.
J Gen Virol ; 100(3): 403-413, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30688635

RESUMEN

Bats are the reservoir hosts for multiple viruses with zoonotic potential, including coronaviruses, paramyxoviruses and filoviruses. Urine collected from Australian pteropid bats was assessed for the presence of paramyxoviruses. One of the viruses isolated was Teviot virus (TevPV), a novel rubulavirus previously isolated from pteropid bat urine throughout the east coast of Australia. Here, we further characterize TevPV through analysis of whole-genome sequencing, growth kinetics, antigenic relatedness and the experimental infection of ferrets and mice. TevPV is phylogenetically and antigenically most closely related to Tioman virus (TioPV). Unlike many other rubulaviruses, cell receptor attachment by TevPV does not appear to be sialic acid-dependent, with the receptor for host cell entry being unknown. The infection of ferrets and mice suggested that TevPV has a low pathogenic potential in mammals. Infected ferrets seroconverted by 10 days post-infection without clinical signs of disease. Furthermore, infected ferrets did not shed virus in any respiratory secretions, suggesting a low risk of onward transmission of TevPV. No productive infection was observed in the mouse infection study.


Asunto(s)
Quirópteros/virología , Infecciones por Paramyxoviridae/veterinaria , Paramyxovirinae/aislamiento & purificación , Animales , Australia , Hurones , Genoma Viral , Ratones , Infecciones por Paramyxoviridae/virología , Paramyxovirinae/genética , Paramyxovirinae/patogenicidad , Paramyxovirinae/fisiología , Filogenia , Virulencia
9.
PLoS Pathog ; 14(1): e1006877, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-29381763

RESUMEN

The interferon (IFN) system represents the first line of defense against a wide range of viruses. Virus infection rapidly triggers the transcriptional induction of IFN-ß and IFN Stimulated Genes (ISGs), whose protein products act as viral restriction factors by interfering with specific stages of virus life cycle, such as entry, transcription, translation, genome replication, assembly and egress. Here, we report a new mode of action of an ISG, IFN-induced TDRD7 (tudor domain containing 7) inhibited paramyxovirus replication by inhibiting autophagy. TDRD7 was identified as an antiviral gene by a high throughput screen of an ISG shRNA library for blocking IFN's protective effect against Sendai virus (SeV) replication. The antiviral activity of TDRD7 against SeV, human parainfluenza virus 3 and respiratory syncytial virus was confirmed by its genetic ablation or ectopic expression in several types of mouse and human cells. TDRD7's antiviral action was mediated by its ability to inhibit autophagy, a cellular catabolic process which was robustly induced by SeV infection and required for its replication. Mechanistic investigation revealed that TDRD7 interfered with the activation of AMP-dependent kinase (AMPK), an enzyme required for initiating autophagy. AMPK activity was required for efficient replication of several paramyxoviruses, as demonstrated by its genetic ablation or inhibition of its activity by TDRD7 or chemical inhibitors. Therefore, our study has identified a new antiviral ISG with a new mode of action.


Asunto(s)
Antivirales/farmacología , Autofagia , Interferones/farmacología , Paramyxovirinae/fisiología , Ribonucleoproteínas/fisiología , Replicación Viral/efectos de los fármacos , Animales , Autofagia/genética , Autofagia/inmunología , Células Cultivadas , Regulación de la Expresión Génica/efectos de los fármacos , Células HEK293 , Células HeLa , Humanos , Inmunidad Innata/efectos de los fármacos , Inmunidad Innata/genética , Ratones , Ratones Endogámicos C57BL , Ribonucleoproteínas/genética , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Replicación Viral/genética
10.
J Gen Virol ; 97(10): 2463-2481, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27498841

RESUMEN

Genome replication and virion production by most negative-sense RNA viruses (NSVs) occurs exclusively in the cytoplasm, but many NSV-expressed proteins undergo active nucleocytoplasmic trafficking via signals that exploit cellular nuclear transport pathways. Nuclear trafficking has been reported both for NSV accessory proteins (including isoforms of the rabies virus phosphoprotein, and V, W and C proteins of paramyxoviruses) and for structural proteins. Trafficking of the former is thought to enable accessory functions in viral modulation of antiviral responses including the type I IFN system, but the intranuclear roles of structural proteins such as nucleocapsid and matrix proteins, which have critical roles in extranuclear replication and viral assembly, are less clear. Nevertheless, nuclear trafficking of matrix protein has been reported to be critical for efficient production of Nipah virus and Respiratory syncytial virus, and nuclear localization of nucleocapsid protein of several morbilliviruses has been linked to mechanisms of immune evasion. Together, these data point to the nucleus as a significant host interface for viral proteins during infection by NSVs with otherwise cytoplasmic life cycles. Importantly, several lines of evidence now suggest that nuclear trafficking of these proteins may be critical to pathogenesis and thus could provide new targets for vaccine development and antiviral therapies.


Asunto(s)
Núcleo Celular/virología , Citoplasma/virología , Infecciones por Paramyxoviridae/virología , Paramyxovirinae/fisiología , Animales , Humanos , Paramyxovirinae/genética , Ensamble de Virus
11.
PLoS One ; 11(6): e0155252, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27304985

RESUMEN

Hendra virus (HeV) is an important emergent virus in Australia known to infect horses and humans in certain regions of the east coast. Whilst pteropid bats ("flying foxes") are considered the natural reservoir of HeV, which of the four mainland species is the principal reservoir has been a source of ongoing debate, particularly as shared roosting is common. To help resolve this, we sampled a colony consisting of just one of these species, the grey-headed flying fox, (Pteropus poliocephalus), at the southernmost extent of its range. Using the pooled urine sampling technique at approximately weekly intervals over a two year period, we determined the prevalence of HeV and related paramyxoviruses using a novel multiplex (Luminex) platform. Whilst all the pooled urine samples were negative for HeV nucleic acid, we successfully identified four other paramyxoviruses, including Cedar virus; a henipavirus closely related to HeV. Collection of serum from individually caught bats from the colony showed that antibodies to HeV, as estimated by a serological Luminex assay, were present in between 14.6% and 44.5% of animals. The wide range of the estimate reflects uncertainties in interpreting intermediate results. Interpreting the study in the context of HeV studies from states to the north, we add support for an arising consensus that it is the black flying fox and not the grey-headed flying fox that is the principal source of HeV in spillover events to horses.


Asunto(s)
Quirópteros/virología , Virus Hendra/fisiología , Infecciones por Henipavirus/virología , Enfermedades de los Caballos/virología , Caballos/virología , Animales , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/inmunología , Anticuerpos Antivirales/orina , Australia/epidemiología , Reservorios de Enfermedades/virología , Geografía , Virus Hendra/inmunología , Infecciones por Henipavirus/epidemiología , Infecciones por Henipavirus/transmisión , Interacciones Huésped-Patógeno , Humanos , Infecciones por Paramyxoviridae/epidemiología , Infecciones por Paramyxoviridae/transmisión , Infecciones por Paramyxoviridae/virología , Paramyxovirinae/inmunología , Paramyxovirinae/fisiología , Prevalencia , Estaciones del Año , Factores de Tiempo , Zoonosis/virología
13.
Vet Microbiol ; 182: 213-22, 2016 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-26711050

RESUMEN

Ferlaviruses are important pathogens of snakes. However, factors influencing the pathogenicity of individual isolates as well as optimal protocols for virus detection in tissues of infected snakes have been insufficiently studied. The objectives of this study were to compare virus detection using previously described PCR and cell culture protocols following infection with three genetically distinct ferlaviruses in corn snakes (Pantherophis guttatus) as a model species. Groups of 12 corn snakes were each inoculated intratracheally with a genogroup A, B, or C ferlavirus. Tracheal washes and cloacal swabs were tested for virus shedding on days 16 and 28. Three animals were each euthanized on days 4, 16, 28, and 49. Beside immunohistochemistry of lung tissue, several organs (lung, intestine, pancreas, kidney, brain) were tested for the presence of ferlavirus. Distinct differences were noted in the pathogenicity of the three viruses, with a genotype B isolate causing the greatest pathology. PCR was more sensitive in comparison to cell culture, but results varied depending on the tissues. Ferlaviruses spread rapidly into the tissues, including the brain. Overall average detection rate was 72%, and was highest on day 16. There were differences between the groups, with the most virulent strain causing 100% positive samples at the end of the study. Some snakes were able to clear the infection. Shedding via cloaca was seen only on day 28. For ante-mortem sampling, a tracheal wash sample is recommended, for post mortem diagnosis, a pooled organ sample should be tested.


Asunto(s)
Colubridae/virología , Infecciones por Paramyxoviridae/veterinaria , Paramyxovirinae/genética , Animales , Células Cultivadas , Modelos Animales de Enfermedad , Infecciones por Paramyxoviridae/genética , Infecciones por Paramyxoviridae/fisiopatología , Infecciones por Paramyxoviridae/virología , Paramyxovirinae/patogenicidad , Paramyxovirinae/fisiología , Tráquea/virología , Esparcimiento de Virus
14.
Viruses ; 7(6): 2858-83, 2015 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-26053927

RESUMEN

Viroporins are members of a rapidly growing family of channel-forming small polypeptides found in viruses. The present review will be focused on recent structural and protein-protein interaction information involving two viroporins found in enveloped viruses that target the respiratory tract; (i) the envelope protein in coronaviruses and (ii) the small hydrophobic protein in paramyxoviruses. Deletion of these two viroporins leads to viral attenuation in vivo, whereas data from cell culture shows involvement in the regulation of stress and inflammation. The channel activity and structure of some representative members of these viroporins have been recently characterized in some detail. In addition, searches for protein-protein interactions using yeast-two hybrid techniques have shed light on possible functional roles for their exposed cytoplasmic domains. A deeper analysis of these interactions should not only provide a more complete overview of the multiple functions of these viroporins, but also suggest novel strategies that target protein-protein interactions as much needed antivirals. These should complement current efforts to block viroporin channel activity.


Asunto(s)
Coronavirus/fisiología , Paramyxovirinae/fisiología , Porinas/metabolismo , Proteínas Oncogénicas de Retroviridae/metabolismo , Proteínas del Envoltorio Viral/metabolismo , Animales , Antivirales/aislamiento & purificación , Antivirales/farmacología , Eliminación de Gen , Humanos , Unión Proteica , Conformación Proteica , Mapeo de Interacción de Proteínas , Proteínas Oncogénicas de Retroviridae/antagonistas & inhibidores , Proteínas Oncogénicas de Retroviridae/genética , Técnicas del Sistema de Dos Híbridos , Proteínas del Envoltorio Viral/antagonistas & inhibidores , Proteínas del Envoltorio Viral/genética
15.
Virology ; 479-480: 259-70, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25816764

RESUMEN

Emerging and well-known viral diseases remain one the most important global public health threats. A better understanding of their pathogenesis and mechanisms of transmission requires animal models that accurately reproduce these aspects of the disease. Here we review the role of ferrets as an animal model for the pathogenesis of different respiratory viruses with an emphasis on influenza and paramyxoviruses. We will describe the anatomic and physiologic characteristics that contribute to the natural susceptibility of ferrets to these viruses, and provide an overview of the approaches available to analyze their immune responses. Recent insights gained using this model will be highlighted, including the development of new prophylactic and therapeutic approaches. To provide decision criteria for the use of this animal model, its strengths and limitations will be discussed.


Asunto(s)
Modelos Animales de Enfermedad , Hurones , Orthomyxoviridae/fisiología , Paramyxovirinae/fisiología , Infecciones del Sistema Respiratorio/patología , Virosis/patología , Animales , Control de Enfermedades Transmisibles , Susceptibilidad a Enfermedades , Interacciones Huésped-Patógeno , Humanos , Orthomyxoviridae/patogenicidad , Paramyxovirinae/patogenicidad , Infecciones del Sistema Respiratorio/inmunología , Infecciones del Sistema Respiratorio/prevención & control , Infecciones del Sistema Respiratorio/terapia , Virosis/inmunología , Virosis/prevención & control , Virosis/terapia
16.
Viruses ; 6(8): 3019-54, 2014 Aug 07.
Artículo en Inglés | MEDLINE | ID: mdl-25105277

RESUMEN

Paramyxoviruses are a family of negative sense RNA viruses whose members cause serious diseases in humans, such as measles virus, mumps virus and respiratory syncytial virus; and in animals, such as Newcastle disease virus and rinderpest virus. Paramyxovirus particles form by assembly of the viral matrix protein, the ribonucleoprotein complex and the surface glycoproteins at the plasma membrane of infected cells and subsequent viral budding. Two major glycoproteins expressed on the viral envelope, the attachment protein and the fusion protein, promote attachment of the virus to host cells and subsequent virus-cell membrane fusion. Incorporation of the surface glycoproteins into infectious progeny particles requires coordinated interplay between the three viral structural components, driven primarily by the matrix protein. In this review, we discuss recent progress in understanding the contributions of the matrix protein and glycoproteins in driving paramyxovirus assembly and budding while focusing on the viral protein interactions underlying this process and the intracellular trafficking pathways for targeting viral components to assembly sites. Differences in the mechanisms of particle production among the different family members will be highlighted throughout.


Asunto(s)
Glicoproteínas/metabolismo , Paramyxovirinae/fisiología , Proteínas del Envoltorio Viral/metabolismo , Ensamble de Virus , Liberación del Virus , Animales , Humanos , Proteínas de la Matriz Viral/metabolismo
17.
PLoS One ; 9(12): e115588, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25551455

RESUMEN

Bats are known to harbor multiple paramyxoviruses. Despite the creation of two new genera, Aquaparamyxovirus and Ferlavirus, to accommodate this increasing diversity, several recently isolated or characterized viruses remain unclassified beyond the subfamily level. In the present study, among 985 bats belonging to 6 species sampled in the Belinga caves of Gabon, RNA of an unclassified paramyxovirus (Belinga bat virus, BelPV) was discovered in 14 African sheath-tailed bats (Coleura afra), one of which exhibited several hemorrhagic lesions at necropsy, and viral sequence was obtained in two animals. Phylogenetically, BelPV is related to J virus and Beilong virus (BeiPV), two other unclassified paramyxoviruses isolated from rodents. In the diseased BelPV-infected C. afra individual, high viral load was detected in the heart, and the lesions were consistent with those reported in wild rodents and mice experimentally infected by J virus. BelPV was not detected in other tested bat species sharing the same roosting sites and living in very close proximity with C. afra in the two caves sampled, suggesting that this virus may be host-specific for C. afra. The mode of transmission of this paramyxovirus in bat populations remains to be discovered.


Asunto(s)
Quirópteros/virología , Especificidad del Huésped , Paramyxovirinae/aislamiento & purificación , Animales , Especificidad de Órganos , Paramyxovirinae/clasificación , Paramyxovirinae/fisiología , Filogenia
18.
PLoS One ; 8(8): e72942, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24023659

RESUMEN

Bats (Chiroptera) host major human pathogenic viruses including corona-, paramyxo, rhabdo- and filoviruses. We analyzed six different cell lines from either Yinpterochiroptera (including African flying foxes and a rhinolophid bat) or Yangochiroptera (genera Carollia and Tadarida) for susceptibility to infection by different enveloped RNA viruses. None of the cells were sensitive to infection by transmissible gastroenteritis virus (TGEV), a porcine coronavirus, or to infection mediated by the Spike (S) protein of SARS-coronavirus (SARS-CoV) incorporated into pseudotypes based on vesicular stomatitis virus (VSV). The resistance to infection was overcome if cells were transfected to express the respective cellular receptor, porcine aminopeptidase N for TGEV or angiotensin-converting enzyme 2 for SARS-CoV. VSV pseudotypes containing the S proteins of two bat SARS-related CoV (Bg08 and Rp3) were unable to infect any of the six tested bat cell lines. By contrast, viral pseudotypes containing the surface protein GP of Marburg virus from the family Filoviridae infected all six cell lines though at different efficiency. Notably, all cells were sensitive to infection by two paramyxoviruses (Sendai virus and bovine respiratory syncytial virus) and three influenza viruses from different subtypes. These results indicate that bat cells are more resistant to infection by coronaviruses than to infection by paramyxoviruses, filoviruses and influenza viruses. Furthermore, these results show a receptor-dependent restriction of the infection of bat cells by CoV. The implications for the isolation of coronaviruses from bats are discussed.


Asunto(s)
Quirópteros/virología , Coronavirus/fisiología , Filoviridae/fisiología , Orthomyxoviridae/fisiología , Paramyxovirinae/fisiología , Virosis/veterinaria , Enzima Convertidora de Angiotensina 2 , Animales , Bovinos , Línea Celular , Proteínas de Unión al GTP/metabolismo , Humanos , Peptidil-Dipeptidasa A/metabolismo , Tripsina/metabolismo , Proteínas Virales/metabolismo , Virosis/virología
19.
J Virol ; 87(21): 11930-5, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23966399

RESUMEN

Here, we show that human parainfluenza viruses and Sendai virus (SeV), like other respiratory viruses, use TMPRSS2 for their activation. The membrane fusion proteins of respiratory viruses often possess serine and glutamine residues at the P2 and P3 positions, respectively, but these residues were not critical for cleavage by TMPRSS2. However, mutations of these residues affected SeV growth in specific epithelial cell lines, suggesting the importance of these residues for SeV replication in epithelia.


Asunto(s)
Interacciones Huésped-Patógeno , Paramyxovirinae/fisiología , Serina Endopeptidasas/metabolismo , Replicación Viral , Animales , Línea Celular , Células Epiteliales/virología , Humanos , Carga Viral , Ensayo de Placa Viral
20.
J Virol ; 87(16): 9250-9, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23785199

RESUMEN

Parainfluenza virus 5 (PIV5) activates and is neutralized by the alternative pathway (AP) in normal human serum (NHS) but not by heat-inactivated (HI) serum. We have tested the relationship between the fusion activity within the PIV5 F protein, the activation of complement pathways, and subsequent complement-mediated virus neutralization. Recombinant PIV5 viruses with enhanced fusion activity were generated by introducing point mutations in the F fusogenic peptide (G3A) or at a distal site near the F transmembrane domain (S443P). In contrast to wild-type (WT) PIV5, the mutant G3A and S443P viruses were neutralized by both NHS and HI serum. Unlike WT PIV5, hyperfusogenic G3A and S443P viruses were potent C4 activators, C4 was deposited on NHS-treated mutant virions, and the mutants were neutralized by factor B-depleted serum but not by C4-depleted serum. Antibodies purified from HI human serum were sufficient to neutralize both G3A and S443P viruses in vitro but were ineffective against WT PIV5. Electron microscopy data showed greater deposition of purified human antibodies on G3A and S443P virions than on WT PIV5 particles. These data indicate that single amino acid changes that enhance the fusion activity of the PIV5 F protein shift the mechanism of complement activation in the context of viral particles or on the surface of virus-infected cells, due to enhanced binding of antibodies. We present general models for the relationship between enhanced fusion activity in the paramyxovirus F protein and increased susceptibility to antibody-mediated neutralization.


Asunto(s)
Proteínas del Sistema Complemento/inmunología , Viabilidad Microbiana/efectos de los fármacos , Paramyxovirinae/inmunología , Paramyxovirinae/fisiología , Proteínas Virales de Fusión/inmunología , Proteínas Virales de Fusión/metabolismo , Internalización del Virus , Animales , Anticuerpos Neutralizantes/inmunología , Anticuerpos Antivirales/inmunología , Línea Celular , Análisis Mutacional de ADN , Humanos , Microscopía Electrónica de Transmisión , Microscopía Inmunoelectrónica , Proteínas Mutantes/genética , Proteínas Mutantes/inmunología , Proteínas Mutantes/metabolismo , Pruebas de Neutralización , Paramyxovirinae/genética , Mutación Puntual , Proteínas Virales de Fusión/genética , Ensayo de Placa Viral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...